The number of drugs available in prefilled syringes as a percentage of all injectable drugs continues to grow. So too does the number of injectable drugs indicated for chronic conditions and self-administration. But suppliers of autoinjectors face several challenges as the market evolves and matures. Continued interest in plastic prefilled syringes will require non-brand specific injector manufacturers to validate that their devices function consistently and safely over the range of these emerging PFS devices - devices with rigidity, barrel lubricity and flexural properties that differ not insignificantly from type 1 glass. They will have to compete - in some cases head-on - with prefilled syringe suppliers, who are increasingly incorporating autoinjector-like ease-of-use features into their PFS designs to differentiate their product lines and in some cases to meet their pharma customer requirements for product-specific syringe designs.
What You Will Learn
- What autoinjectors can be paired with prefilled syringes for injectable drug delivery; what are the key market segments, market dynamics and market demographics?
- What are the therapeutic demand drivers and commercial devices in key product segments?
- What are the design factors, material selection issues, technologies and market development issues?
- How big is the market? How is it growing? What will it look like in 2026?
- Who are the leading injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations?
- What is the importance of pharma-device alliances and design partnerships on autoinjector commercialization and market access?
- What is the impact of wirelessly connected autoinjectors on patient care and market growth?
- What are the significant economic, technology, and regulatory factors affecting the market for autoinjectors?
Report Value Matrix
- Managed Care Managers
- Management Consultants
- Financial Analysts
- Pharma Product Managers
- Device Suppliers
- Biotech Managers
- Drug Marketers & Strategists
- Product Developers
- Component Suppliers
- CMOs, CSOs
- Clinical Managers
- Drug Distributors
- Pharma Regulators
1. Executive Summary
2. The Market Opportunity
- Delivery Market Dynamics
- The Economics of Injectable Drugs
- What’s Driving the Growth in Autoinjectors?
- Prefilled Syringes Proliferating
- The Trend toward Self-Administration
- Shifting Demographics
- Innovation in Disposable Device Designs
- Therapeutic Demand Drivers
- Competitive Landscape
- Risk Factors
3. Autoinjectors - Commercial Devices
- Manual Injection Autoinjectors
- Automated Injection Autoinjectors
- Reusable Autoinjectors
- Disposable Autoinjectors
- Variable Dose Autoinjectors
- Product Specific Autoinjectors
4. Autoinjector Device Design Factors
- Material Selection Issues
- Part Counts and Device Cost
- Safety Features
- Needle Shielding
- Needle Insertion Depth
- Failsafe Activation
- Dose Inspection/Injection Confirmation
- Lyophilized Drugs/Reconstitution
- Human Engineering/Ergonomics
5. Autoinjector Drug Delivery - Key Therapeutic Sector Analysis
- Autoimmune Diseases
- Rheumatoid Arthritis
- Multiple Sclerosis
- Emergency Medicine
- Reproductive Health
6. Market Factors
- Regulatory Issues
- Device Branding
- Patient Compliance and Ease of Use
- Healthcare Economics
The Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.
Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.
Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.